Drugs that contain Oxcarbazepine

1. List of Oxtellar Xr drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10220042 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(4 years from now)

US9119791 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(4 years from now)

US7910131 SUPERNUS PHARMS Method of treating seizures using modified release formulations of oxcarbazepine
Apr, 2027

(4 years from now)

US9855278 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(4 years from now)

US11166960 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(4 years from now)

US8821930 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(4 years from now)

US9351975 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(4 years from now)

US7722898 SUPERNUS PHARMS Modified-release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(4 years from now)

US8617600 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(4 years from now)

US9370525 SUPERNUS PHARMS Modified release preparations containing oxcarbazepine and derivatives thereof
Apr, 2027

(4 years from now)

Market Authorisation Date: 19 October, 2012

Treatment: Treatment of partial-onset seizures

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of OXTELLAR XR before it's patent expiration?
More Information on Dosage

OXTELLAR XR family patents

17

United States

2

Japan

2

Spain

2

European Union

1

Germany

1

Austria

1

Canada

1

Australia

1

Mexico

1

China

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic